Biotech stocks: are they worth a shot?
Despite some huge gains over the last few weeks,...
Despite some huge gains over the last few weeks,...
Price-to-earnings ratio is a good (if imperfect) starting point...
Because of the uncertainty around the COVID-19 crisis, many...
With companies now beginning to report on Q1 results,...
While stocks are still down by about 20% since...
For those who are considering whether to take any...
Four investing professionals offer thoughts on the current state...
It’s hard enough to understand how regular interest rates...
With the speed at which the disease and its...